Supermicro CEO insists ‘no one’ beyond indicted employees were involved in alleged $2.5 billion smuggling scheme

Super Micro reported Q3 revenue of $10.2 billion, up 123% year over year, with non-GAAP EPS of $0.84 beating guidance of at least $0.60 and gross margin improving to 10.1% from 6.4% last quarter. The company raised Q4 revenue guidance to $11 billion-$12.5 billion and lifted its FY2026 target to $38.9 billion-$40.4 billion, even as it faced ongoing fallout from a DOJ export-controls investigation. Shares rose 18% after hours as management said it does not currently expect an earnings restatement and believes no additional employees were involved.

Analysis

The market is treating the call as an earnings reset with a legal overhang shrinking faster than feared, but the more important implication is that SMCI is trying to re-anchor credibility before customers re-source design wins. If management can keep hyperscaler allocation intact while enterprise mix expands, the gross margin step-up is more durable than a one-quarter print; that matters because every 100 bps of margin in this model flows disproportionately to EPS and perceived quality. The bigger second-order winner is the GPU supply chain: a cleaner SMCI path supports continued acceleration in accelerator deployment, which is incrementally supportive for NVDA, AMD, INTC, and AVGO through higher server attach rates rather than direct share gains.

The main risk is not the indictment itself but the investigation’s timeline mismatch versus customer procurement cycles. Even if no additional misconduct is found, enterprise buyers and regulated end-markets can slow purchase decisions for 1-2 quarters while they reassess compliance diligence, which could push deferred revenue recognition out and create air pockets in revenue timing. A more subtle downside is channel concentration: if the recently reduced hyperscaler mix rebounds too quickly, margin optimism could fade and the stock would rerate back to a lower-quality hardware multiple.

Consensus may be underestimating how much of the after-hours move is a relief rally versus a fundamental de-risking. The stock can still work from here if FY26 guidance proves executable, but the asymmetry shifts from multiple expansion to execution quality; any evidence of customer attrition, audit delays, or supply-chain scrutiny would likely hit the shares harder than the market is pricing. On the other hand, if the company shows two consecutive quarters of improved mix and stable supplier allocations, the market may start valuing SMCI less like a controversy-prone hardware vendor and more like an AI infrastructure platform with operating leverage.

Key Decisions for Investors

• Long SMCI on a 2-6 week horizon only on pullbacks below the post-gap range; the thesis is a continued relief re-rating, but size modestly because legal/operational headline risk can reverse 15-25% quickly.
• Pair trade: long NVDA / short SMCI for 1-3 months if you want AI infrastructure exposure with lower event risk; SMCI has higher idiosyncratic legal and customer-concentration risk, while NVDA benefits from the same capex cycle with cleaner fundamentals.
• Buy SMCI upside call spreads into the next earnings window; target a defined-risk structure because guidance credibility can drive another leg higher, but downside remains binary if the investigation broadens.
• Relative-value long AVGO vs. SMCI over the next quarter; AVGO captures secular AI networking and custom silicon demand with much less governance risk, making it the higher-quality way to express continued AI server buildout.
• Avoid shorting NVDA/AMD/INTC on the headline alone; the article is more supportive of aggregate accelerator demand than of any direct share loss, so any weakness in peers would likely be shallow unless new export-control issues surface.